Evidence map›Paper›PMID 24967635›Full record

ArticlePloS one2014

Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts.

Andrew P Stein, Sandeep Saha, Cheng Z Liu, Gregory K Hartig, Paul F Lambert, Randall J Kimple

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2015
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrew P SteinDepartment of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America; McArdle Laboratory for Cancer Research and Department of Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
Sandeep SahaDepartment of Biostatistics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
Cheng Z LiuDepartment of Pathology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
Gregory K HartigDepartment of Otolaryngology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
Paul F LambertMcArdle Laboratory for Cancer Research and Department of Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
Randall J KimpleDepartment of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America.
University of Wisconsin Carbone Cancer Center · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Head and Neck squamous cell carcinoma radiation response modulation by HPVR00CA160639 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KIMPLE, RANDALL J. · 2013 to 2015
$725k
Head and Neck squamous cell carcinoma radiation response modulation by HPVK99CA160639 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KIMPLE, RANDALL J. · 2011 to 2012
$298k
NCI NIH HHS R00 CA160639
6 · The paper itself

Abstract

backgroundPatient derived xenografts (PDXs) for head and neck cancer (HNC) and other cancers represent powerful research platforms. Most groups implant patient tissue into immunodeficient mice immediately although the significance of this time interval is anecdotal. We tested the hypothesis that the time from tumor excision to implantation is crucial for PDX passaging and establishment.

methodsWe examined whether time or storage medium affected PDX viability for passaging two established HNC PDXs (UW-SCC34, UW-SCC52). Tumors were harvested, stored in ice-cold media or saline for 0-48 hours, and implanted into new mice. Tumor growth was compared by two-way ANOVA with respect to time and storage condition. Three new HNC PDXs (UW-SCC63-65) were generated by implanting patient tissue into mice immediately (Time 0) and 24 hours after receiving tissue from the operating room.

resultsSimilar quantities of tumor were implanted into each mouse. At the end of the experiment, no significant difference was seen in mean tumor weight between the media and saline storage conditions for UW-SCC34 or UW-SCC52 (p = 0.650 and p = 0.177, respectively). No difference in tumor formation prevalence was seen on the basis of time from harvest to implantation (≥13 of 16 tumors grew at every time point). Histological analysis showed strong similarity to the initial tumor across all groups. Tumors developed at both Time 0 and 24 hours for UW-SCC63 and UW-SCC64.

conclusionsWe demonstrated that neither storage medium nor time from tumor excision to implantation (up to 48 hours) affected viability or histological differentiation in a subsequent passage for two HNC PDXs. Moreover, we revealed that fresh patient tissue is viable up to 24 hours post-resection. This information is important as it applies to the development and sharing of PDXs.

Indexed as

Specimen HandlingAnimalsDisease Models, AnimalFemaleHead and Neck NeoplasmsHeterograftsHumansMaleMiceNeoplasm GradingTumor Burden

Identifiers

PMID24967635
PMCPMC4072729
OpenAlexW1980846875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.